This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Apr;289(16):2066-7; author reply 2069-70.

doi: 10.1001/jama.289.16.2066-c.

Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors

Christopher R Palmer, Morris J Brown, Giuseppe Mancia, Luis M Ruilope; INSIGHT Steering Committee

PMID: 12709455
DOI: 10.1001/jama.289.16.2066-c

Comment

Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors

Christopher R Palmer et al. JAMA. 2003 Apr.

. 2003 Apr;289(16):2066-7; author reply 2069-70.

doi: 10.1001/jama.289.16.2066-c.

Authors

Christopher R Palmer, Morris J Brown, Giuseppe Mancia, Luis M Ruilope; INSIGHT Steering Committee

PMID: 12709455
DOI: 10.1001/jama.289.16.2066-c

No abstract available

PubMed Disclaimer

Comment on

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
[No authors listed] [No authors listed] JAMA. 2000 Apr 19;283(15):1967-75. JAMA. 2000. PMID: 10789664 Clinical Trial.
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981. JAMA. 2002. PMID: 12479763 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information